人乳低聚醣（HMO）市场规模、份额及成长分析（按类型、产品类型、应用、通路和地区划分）－2026-2033年产业预测

预计到 2024 年，人类乳寡糖 (HMO) 市场规模将达到 2.2964 亿美元，到 2025 年将达到 2.533 亿美元，到 2033 年将达到 5.5493 亿美元，在预测期（2026-2033 年将达到 5.5493 亿美元，在预测期（2026-2033 年）复合年增长率为 10.3%。

母乳低聚醣 (HMO) 作为婴幼儿健康和营养的关键成分，市场正蓬勃发展。这些天然存在于母乳中的复杂碳水化合物具有显着的健康益处，包括促进婴幼儿免疫系统发育、消化功能和认知能力。人们对 HMO 益处的认识不断提高，推动了市场需求，尤其是在旨在模拟母乳的婴儿奶粉奶粉方面。这一增长与消费者寻求天然和整体健康解决方案的更广泛趋势不谋而合。此外，HMO 的潜在应用不仅限于婴幼儿营养，还包括药品、机能性食品和益生元等领域。然而，HMO 生产的复杂性和高成本，以及监管和智慧财产权方面的挑战，都是必须克服的障碍，才能充分发挥市场的潜力。

人乳低聚醣（HMO）市场驱动因素

人们对母乳寡糖 (HMO) 健康益处的认识不断提高，是推动市场成长的关键因素。随着消费者对 HMO 在增强婴儿免疫功能、促进认知发展和改善肠道健康方面的重要作用了解得越来越深入，对 HMO 强化产品的需求持续成长。此外，HMO 对成人的潜在益处也进一步刺激了消费者的兴趣和消费。这种日益增长的认知促使生产商不断创新，将 HMO 添加到各种产品中，最终满足了注重健康的消费者的需求，并扩大了整个 HMO 市场。

限制人乳低聚醣（HMO）市场的因素

由于人乳低聚醣 (HMO) 合成过程复杂且难度高，HMO 市场面临严峻的挑战。这些製程的复杂性不仅增加了实施难度，也阻碍了 HMO 生产的扩充性和成本效益。复製人乳中存在的各种 HMO 结构需要大量的资源和专业知识，导致生产成本居高不下。这些因素限制了市场成长和普及，使得製造商难以在满足市场需求的同时，维持价格合理和生产效率高。

人乳低聚醣（HMO）市场趋势

随着人们探索婴儿营养以外的应用，人类乳寡糖 (HMO) 市场正经历重大变革。虽然传统上 HMO 与母乳餵养密切相关，但目前越来越多的人开始将其应用于机能性食品、膳食补充剂和治疗产品中，以应对各个年龄层面临的各种健康挑战。这种应用范围的扩大凸显了 HMO 的多方面效用，包括改善肠道健康、增强免疫反应以及潜在地缓解慢性疾病。随着人们对 HMO 益处的认识不断加深，预计 HMO 在主流保健产品中的应用将加速，从而创造新的机会，并推动机能性食品和膳食补充剂领域的市场成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球人乳低聚醣（HMO）市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 2'FL
• 3'FL
• 3'SL
• 6'SL

全球人乳低聚醣（HMO）市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 岩藻糖基乳糖
• Lnt 和 LNnt
• 唾液酸乳糖

全球人乳低聚醣（HMO）市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 婴儿奶粉
• 功能性食品和饮料
• 营养补充品
• 人类和动物保健成分
• 其他的

全球人乳低聚醣（HMO）市场规模（依分销通路划分）及复合年增长率（2026-2033 年）

• 大卖场和超级市场
• 药局或药房
• 量贩店
• 百货公司
• 单品牌商店
• 专卖店
• 线上销售管道

全球人乳低聚醣（HMO）市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• DSM（Netherlands）
• BASF SE（Germany）
• DuPont（US）
• Nestle（Switzerland）
• Inbiose NV（Belgium）
• Gnubiotics Sciences SA（Switzerland）
• Abbott Laboratories（US）
• Royal FrieslandCampina NV（Netherlands）
• Elicityl SA（France）
• Dextra Laboratories（UK）
• Glycom A/S（Denmark）
• Glycosyn（US）
• Medolac Laboratories（US）
• Neolacta Lifesciences Pvt. Ltd.（India）
• Jennewein Biotechnologie GmbH（Germany）
• Lonza Specialty Ingredients（Switzerland）
• Kirin Holdings Company（Kyowa Hakko Bio）（Japan）
• ZuChem Inc.（US）

结论与建议

Human Milk Oligosaccharides (HMO) Market size was valued at USD 229.64 Million in 2024 and is poised to grow from USD 253.3 Million in 2025 to USD 554.93 Million by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The Human Milk Oligosaccharides (HMO) market is gaining traction as a crucial aspect of infant wellness and nutrition. These naturally occurring complex carbohydrates found in breast milk offer significant health benefits, promoting the development of the infant's immune system, gastrointestinal function, and cognitive skills. Increased awareness of their advantages fuels demand, particularly for infant formulas that aim to mimic breast milk. This growth aligns with a broader consumer trend toward seeking natural and holistic health solutions. Additionally, potential applications for HMOs extend beyond infant nutrition into pharmaceuticals, functional foods, and prebiotics. However, the complexity and high costs associated with HMO production, coupled with regulatory and intellectual property challenges, present hurdles that must be navigated to fully realize market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Human Milk Oligosaccharides (HMO) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Human Milk Oligosaccharides (HMO) Market Segments Analysis

Global Human Milk Oligosaccharides (HMO) Market is segmented by Type, Product, Application, Distribution channel and region. Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL and 6'SL. Based on Product, the market is segmented into Fucosyllactose, Lnt & LNnt and Sialyllactose. Based on Application, the market is segmented into Infant formula, Functional food & beverages, Food supplements, Health ingredients for human and animal and Other. Based on Distribution channel, the market is segmented into Hypermarkets and supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental stores, Mono-brand stores, Specialty stores and Online sales channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits associated with human milk oligosaccharides (HMOs) is a significant catalyst for market growth. As consumers become more informed about the essential role HMOs play in enhancing immune function, supporting cognitive development, and improving gut health in infants, the demand for HMO-fortified products continues to rise. Additionally, the potential advantages of HMOs for adults are further boosting interest and consumption. This growing awareness is driving manufacturers to innovate and incorporate HMOs into a variety of products, ultimately catering to the health-conscious market and expanding the overall HMO market landscape.

Restraints in the Human Milk Oligosaccharides (HMO) Market

The Human Milk Oligosaccharides (HMO) market faces significant challenges due to the intricate and challenging processes involved in HMO synthesis. The complexity of these procedures not only makes them difficult to execute but also hampers the scalability and cost-effectiveness of HMO manufacturing. Replicating the diverse array of HMO structures found in breast milk requires substantial resources and expertise, which can result in higher production costs. These factors can limit market growth and accessibility, making it difficult for manufacturers to meet demand while maintaining affordability and efficiency in their production processes.

Market Trends of the Human Milk Oligosaccharides (HMO) Market

The Human Milk Oligosaccharides (HMO) market is witnessing a significant shift as research explores their applications beyond infant nutrition. While traditionally associated with breastfeeding, there is a growing trend to utilize HMOs in functional foods, dietary supplements, and therapeutics aimed at addressing various health concerns across diverse age groups. This expanded focus highlights the versatility of HMOs in enhancing gut health, boosting immune response, and potentially mitigating chronic diseases. As the understanding of HMO benefits evolves, their incorporation into mainstream health products is likely to accelerate, creating new opportunities and driving market growth in the functional food and health supplement sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Human Milk Oligosaccharides (HMO) Market Size by Type & CAGR (2026-2033)

• Market Overview
• 2'FL
• 3'FL
• 3'SL
• 6'SL

Global Human Milk Oligosaccharides (HMO) Market Size by Product & CAGR (2026-2033)

• Market Overview
• Fucosyllactose
• Lnt & LNnt
• Sialyllactose

Global Human Milk Oligosaccharides (HMO) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Infant formula
• Functional food & beverages
• Food supplements
• Health ingredients for human and animal
• Other

Global Human Milk Oligosaccharides (HMO) Market Size by Distribution channel & CAGR (2026-2033)

• Market Overview
• Hypermarkets and supermarkets
• Drug store or pharmacy
• Mass merchandiser
• Departmental stores
• Mono-brand stores
• Specialty stores
• Online sales channel

Global Human Milk Oligosaccharides (HMO) Market Size & CAGR (2026-2033)

• North America (Type, Product, Application, Distribution channel)
  • US
  • Canada
• Europe (Type, Product, Application, Distribution channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Application, Distribution channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Application, Distribution channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Application, Distribution channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inbiose NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gnubiotics Sciences S.A (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal FrieslandCampina N.V (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elicityl S.A (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dextra Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycom A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glycosyn (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medolac Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neolacta Lifesciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jennewein Biotechnologie GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Specialty Ingredients (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirin Holdings Company (Kyowa Hakko Bio) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZuChem Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations